Drug Pricing Pattern in China: Dilemma and Countermeasure
Maybe it is the most important medical reform for current China to adopt the bid-and-procurement scheme to correct the distortion of pharmaceutical resources allocation. Nevertheless, overpriced drugs often happen. This article aims to identify potential factors leading to the overpriced. Based on the mechanism rules of the scheme, it is found that unethical doctors are crucial to high price markup in the pricing pattern of drugs. Under China's actual conditions, asymmetric ownership is identified to be another cause of the overpriced by developing an asymmetric bidding model. How are the impacts of these two factors to be alleviated? Upon examination, several reform measures cannot effectively avoid the occurrence of the overpriced. Yet, the issue is very urgent for China because it is facing with the problem of population aging. Therefore, alternative options - a regulation-penalty tool and an investment subsidy policy - are proposed to improve China's health care.
KeywordsThe bid-and-procurement scheme overpriced drug asymmetry health-care reform
Unable to display preview. Download preview PDF.
We are indebted to two anonymous referees for their help to improve the quality of the paper and Prof. Shouyang Wang for encouragement and detailed comments on an earlier draft. During this research, we have benefited from the financial support of National Natural Science Foundation of China (No. 71471039) and CityU 11301014 of the Government of Hong Kong SAR.
- Hanazonoy, M., Nakabayashi, J. & Tsuruoka, M. (2012). A theory ofmultidimensional auctions with non-quasi-linear scoring rules. Paper presented atthe39th Annual Conference of European Association for Research inIndustrial Economics, 2-4 September, 2012, Rome.Google Scholar
- Liu, X.Z. & Hsiao, W.C.L. (1995). The cost escalation of social healthinsurance plans in China: its implication for public policy. SocialScience & Medicine, 41(8): 1095–1101.Google Scholar
- McAfee, R.P. & McMillan, J. (1987). Auction and bidding. Journal ofEconomic Literature, 25(2): 99–738.Google Scholar
- Yan, J. & Shao R. (2012). Influence analysis of “Double envelope”system on the quality of essential drugs. Qilu Pharmaceutical Affairs, 31(1): 51–53. (In Chinese)Google Scholar
- Yang, J. (2012). Price: people unbearable weight. Guangdong Party, 2: 28–29.Google Scholar
- Yoon, K.P. & Hwang, C.L. (1995). Multiple attribute decision making:an introduction. Sage University Paper Series on QuantitativeApplications in the Social Science, 07-104, Thousand Oaks, CA:Sage.Google Scholar
- Yu, B.Y., Meng, Q.Y., Collins, C., Tolhurst, R., Tang, S.L., Yan, F., Bogg, L. & Liu, X.Y. (2010). How does the new cooperative medical schemeinfluence health service utilization? A study in two provinces inrural China. BMC Health Services Research, 10(116): 1–9.Google Scholar
- Yu, X. & Tang, S. (2015). Study on correlation between quality and price in bidding procurement for essential drugs. China Medical Herald, 12(8): 105–108. (In Chinese)Google Scholar